Idexx Laboratories (IDXX) Stock Price, Quote & News

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test ki...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 207 556 0300

Fax: 207 556 4346

Website: www.idexx.com

Address:

One IDEXX Drive, Westbrook, United States

ZacksResearch Aug. 25 at 1:24 PM

$IDXX surges 56.2% YTD — Is it time to ride the wave? 🚀 Despite industry challenges, IDEXX continues to outperform with an 11% organic rise in international CAG diagnostics and double-digit growth in cloud-native PIMS platforms. The company also raised its 2025 financial outlook, expecting total revenue growth of 7.7-9.7% and EPS growth of 16-20% YoY. 📈 See what makes IDEXX a solid wealth creator now 👉 https://www.zacks.com/stock/news/2741980/idexx-gains-562-in-a-year-whats-driving-the-rally?cid=sm-stocktwits-2-2741980-body-9259&ADID=SYND_STOCKTWITS_TWEET_2_2741980_BODY_9259

0 · Reply

ZacksResearch Aug. 25 at 12:24 PM

$IDXX up 56% in a year — but what’s fueling the surge? 📈 Strong diagnostics growth, cloud software momentum, and an upbeat 2025 outlook are powering the rally. Full breakdown of what’s driving IDXX higher 👉 https://www.zacks.com/stock/news/2741980/idexx-gains-562-in-a-year-whats-driving-the-rally?cid=sm-stocktwits-2-2741980-teaser-9258&ADID=SYND_STOCKTWITS_TWEET_2_2741980_TEASER_9258

0 · Reply

StockAutoPro Aug. 23 at 4:01 PM

$IDXX: Buy target $643.55 Sell target $677.83 Strong pet adoption trends could boost growth for a leading veterinary diagnostics company.

0 · Reply

healthcareguru Aug. 21 at 3:14 PM

$IDXX <$600

0 · Reply

SmartMoneyTradez Aug. 19 at 4:50 PM

$IDXX 638 atm. Gap at 538. 100 dollar drop inbound. PUTs

0 · Reply

LamboTrap Aug. 18 at 3:19 PM

$IDXX Idexx dominates veterinary diagnostics but faces growth questions as pandemic pet boom normalizes.

0 · Reply

JarvisFlow Aug. 15 at 1:00 PM

Morgan Stanley updates rating for IDEXX Laboratories ( $IDXX ) to Overweight, target set at 722 → 765.

0 · Reply

theoptionsplug Aug. 14 at 4:53 AM

Things to Watch Thursday 👀 - Electronic Arts $EA will launch Madden NFL 2026 on PlayStation 5, Xbox Series X|S, PC, and Nintendo Switch 2 🏈 - 7:00AM: Deadline for investment managers and hedge funds to report Q1 holdings ⏳ - 8:30AM: Initial jobless claims will be released 💼 - 8:30AM: Producer price index for July will be released 📊 - 10:00AM: IDEXX Laboratories $IDXX will host its Investor Day 🧪 - 2:00PM: Richmond Fed President Tom Barkin speaks 🎙️

0 · Reply

JarvisFlow Aug. 11 at 12:30 PM

Piper Sandler updates rating for IDEXX Laboratories ( $IDXX ) to Neutral, target set at 510 → 700.

0 · Reply

healthcareguru Aug. 8 at 1:15 PM

$IDXX stupidly overvalued and recession coming…punish these price gougers. <$600 incoming. 👎👎

0 · Reply

Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts

ARGX COO ELV HQY INSM ISRG RDNT

Aug 4, 2025, 5:55 PM EDT - 22 days ago

S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes

Aug 4, 2025, 2:37 PM EDT - 22 days ago

IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 1:48 PM EDT - 22 days ago

Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF

DAL IYF TSLA

Aug 4, 2025, 12:15 PM EDT - 22 days ago

Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More

Aug 4, 2025, 10:45 AM EDT - 22 days ago

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation

Aug 4, 2025, 9:10 AM EDT - 22 days ago

IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook

Aug 4, 2025, 7:57 AM EDT - 22 days ago

IDEXX Laboratories raises annual forecasts on strong demand for pet diagnostics

Aug 4, 2025, 6:30 AM EDT - 22 days ago

IDEXX Laboratories Announces Second Quarter Results

Jul 30, 2025, 7:00 AM EDT - 27 days ago

IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals

Jul 17, 2025, 7:06 AM EDT - 5 weeks ago

IDEXX Laboratories: A Business With Strong Fundamentals

Jul 10, 2025, 7:00 AM EDT - 6 weeks ago

IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors

Jun 24, 2025, 1:00 PM EDT - 2 months ago

IDEXX Laboratories to Release 2025 Second Quarter Financial Results

Jun 5, 2025, 7:00 AM EDT - 2 months ago

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

May 14, 2025, 2:35 PM EDT - 3 months ago

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

May 13, 2025, 2:30 PM EDT - 3 months ago

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

May 1, 2025, 10:35 AM EDT - 4 months ago

IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript

May 1, 2025, 8:21 AM EDT - 4 months ago

IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics

May 1, 2025, 6:30 AM EDT - 4 months ago

IDEXX Laboratories Announces First Quarter Results

Apr 3, 2025, 1:30 PM EDT - 5 months ago

IDEXX Laboratories to Release 2025 First Quarter Financial Results

Mar 17, 2025, 5:40 AM EDT - 5 months ago

IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To 'Buy'

Mar 12, 2025, 6:24 AM EDT - 5 months ago

IDEXX Laboratories: A Top Dog In The Pet Care Market

Feb 13, 2025, 2:00 PM EST - 6 months ago

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

Feb 10, 2025, 11:27 AM EST - 7 months ago

IDEXX Laboratories And Its Real Value

Feb 6, 2025, 2:31 PM EST - 7 months ago

IDEXX Laboratories: I See Pet Healthcare As An Interesting Market For The Future

Feb 3, 2025, 11:31 AM EST - 7 months ago

Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today's Top S&P 500 Performers.

ABBV MOH

Feb 3, 2025, 11:26 AM EST - 7 months ago

IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript

Feb 3, 2025, 11:22 AM EST - 7 months ago

IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices

Feb 3, 2025, 9:51 AM EST - 7 months ago

Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?

Feb 3, 2025, 7:57 AM EST - 7 months ago

Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits

Feb 3, 2025, 6:30 AM EST - 7 months ago

IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results

Jan 16, 2025, 4:15 PM EST - 7 months ago

IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results

Dec 19, 2024, 10:09 AM EST - 8 months ago

SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX

SNPS

Dec 9, 2024, 7:30 AM EST - 9 months ago

IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization

Nov 21, 2024, 7:30 AM EST - 9 months ago

IDEXX Announces CFO Transition

Nov 12, 2024, 9:00 AM EST - 10 months ago

ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents

Nov 10, 2024, 7:50 PM EST - 10 months ago

IDEXX Laboratories Q3: Weak End-Market Demand Continues

Oct 31, 2024, 1:59 PM EDT - 10 months ago

IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 1:15 PM EDT - 10 months ago

CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results

Oct 31, 2024, 12:55 PM EDT - 10 months ago

Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth

Oct 31, 2024, 8:01 AM EDT - 10 months ago

IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow

Oct 31, 2024, 6:30 AM EDT - 10 months ago

IDEXX Laboratories Announces Third Quarter Results

Sep 30, 2024, 2:00 PM EDT - 11 months ago

IDEXX Laboratories to Release 2024 Third Quarter Financial Results

Aug 21, 2024, 4:15 PM EDT - 1 year ago

IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 11, 2024, 11:36 PM EDT - 1 year ago

IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits

Aug 6, 2024, 12:48 PM EDT - 1 year ago

Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst

Aug 6, 2024, 12:46 PM EDT - 1 year ago

IDEXX Laboratories, Inc. (IDXX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 3:20 AM EDT - 1 year ago

The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data

AAPL ABNB AMZN BAX CAT CSX DIS

Jul 30, 2024, 5:53 PM EDT - 1 year ago

IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call

Jul 30, 2024, 7:00 AM EDT - 1 year ago

IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals

ZacksResearch Aug. 25 at 1:24 PM

0 · Reply

ZacksResearch Aug. 25 at 12:24 PM

0 · Reply

StockAutoPro Aug. 23 at 4:01 PM

$IDXX: Buy target $643.55 Sell target $677.83 Strong pet adoption trends could boost growth for a leading veterinary diagnostics company.

0 · Reply

healthcareguru Aug. 21 at 3:14 PM

$IDXX <$600

0 · Reply

SmartMoneyTradez Aug. 19 at 4:50 PM

$IDXX 638 atm. Gap at 538. 100 dollar drop inbound. PUTs

0 · Reply

LamboTrap Aug. 18 at 3:19 PM

$IDXX Idexx dominates veterinary diagnostics but faces growth questions as pandemic pet boom normalizes.

0 · Reply

JarvisFlow Aug. 15 at 1:00 PM

Morgan Stanley updates rating for IDEXX Laboratories ( $IDXX ) to Overweight, target set at 722 → 765.

0 · Reply

theoptionsplug Aug. 14 at 4:53 AM

0 · Reply

JarvisFlow Aug. 11 at 12:30 PM

Piper Sandler updates rating for IDEXX Laboratories ( $IDXX ) to Neutral, target set at 510 → 700.

0 · Reply

healthcareguru Aug. 8 at 1:15 PM

$IDXX stupidly overvalued and recession coming…punish these price gougers. <$600 incoming. 👎👎

0 · Reply

1KEI Aug. 8 at 9:43 AM

$IDXX one day ethics will catch up with this operation

0 · Reply

StockAutoPro Aug. 6 at 4:23 PM

$IDXX: Buy target $635.32 Sell target $669.19 Strong pipeline of innovative drugs suggests potential for substantial long-term growth in this healthcare stock.

0 · Reply

healthcareguru Aug. 6 at 3:35 PM

$IDXX back <$600…I told you when it was squeezing. STUPIDLY OVERVALUED in a slowing economy. 👎

0 · Reply

Rajankduggy Aug. 6 at 12:01 AM

$IDXX well that was quicker than I expected …

0 · Reply

TheClockworkGroup Aug. 5 at 9:40 PM

$IDXX #NASDAQ | The markets are unpredictable, but with #WaveE, one of our cutting-edge #AI-driven #algorithmic #breakout #daytrading strategies, you too can make calculated trades like a pro! Scalped profits of $4,246.50 trading #IdexxLaboratoriesInc., $IDXX shares today! Experience 100% automation and compatibility with @MultiCharts, @NinjaTrader & @TradeStation...

0 · Reply

OptionWinners Aug. 5 at 8:52 PM

📢 $ZTS Q2 Earnings Recap Zoetis delivered another strong quarter, beating on both top & bottom lines and raising guidance 🐶💊 💰 EPS: $1.76 vs $1.61 est → ✅ Beat by $0.15 📊 Revenue: $2.50B (+4.2% Y/Y) vs $2.41B est → ✅ Beat by $90M 📆 FY25 Guidance Raised: Revenue: $9.45B–$9.60B (was $9.43B–$9.58B) Adj. EPS: $6.30–$6.40 (was $6.20–$6.30) Organic Revenue Growth: 6.5%–8.0% Organic Adj. Net Income Growth: 5.5%–7.5% 💡 Growth led by Simparica (+17% operational), Key Dermatology (+11%), while Librela saw declines but remains a long-term focus. Shares got a boost as Zoetis continues to show broad-based strength and margin expansion 📈 #Zoetis #ZTS #Earnings #AnimalHealth #PetCare #Pharma #StockMarket #Investing #EarningsSeason #Elanco $ELAN #Idexx $IDXX #Pfizer $PFE

0 · Reply

IN0V8 Aug. 5 at 6:46 PM

$IDXX Opportunity BTIG raises target price to $785 from $545 Jefferies raises target price to $785 from $625 JP Morgan raises target price to $675.00 from $550.00 Morgan Stanley raises target to $722.00 from $626.00

0 · Reply

SmartMoneyTradez Aug. 5 at 4:03 PM

$IDXX expecting 100 $ drop from to 540. Entry once amd is done reporting

0 · Reply

cubie Aug. 5 at 3:52 PM

$IDXX congrats like $SPY pump yesterday, peeps took profits following day, shocker, not🙄

0 · Reply

FetchDog Aug. 5 at 2:21 PM

$IDXX Way over valued company. Very low growth relative to PE. Visits to vets are trending down (look at their earnings snapshot), imagine what happens when the recession gets bad. Their operating margin increase is mostly due to litigation expenses ceasing and foreign exchange. This will drop super hard on next ER as the effect of the recession starts to show. Nothing is worse for a "growth" stock than when they stop growing. 98% institutional ownership. If they wanted to buy, they bought yesterday. The price target increases were probably made in collusion with institutions so they can dump on the heads of retail.

0 · Reply

scientificway Aug. 5 at 11:33 AM

$IDXX Small fast growing, MDXG, huge rev, eps, guidance up. , growth for sure, how much after a year

0 · Reply

TheDayTradingAcademy Aug. 5 at 10:21 AM

The U.S. health-care diagnostics company $IDXX reported Q2 results that beat expectations, sending shares higher by +27.49% on Monday at $682.78. Idexx earned $3.63 per share on revenue of $1.11 billion. Analysts expected a profit of $3.30 per share on revenue of $1.07B. The stock is up +65.15% in 2025 & +45.47% y/y, with a market cap of $54.91B.

0 · Reply

Market Cap	51.65B
Revenue (ttm)	3.90B
Net Income (ttm)	887.87M
EPS (ttm)	N/A
PE Ratio	53.75
Forward PE	51.21
Profit Margin	22.78%
Debt to Equity Ratio	0.36

Volume	416,500
Avg Vol	611,406
Day's Range	N/A - N/A
Shares Out	80.01M
Stochastic %K	29%
Beta	1.49
Analysts	Strong Sell
Price Target	$722.60